Ibrutinib: a strong candidate for the future of mantle cell lymphoma treatment

Author： Zhang Liang   Newberry Kate J   Wang Michael  

Publisher： Informa Healthcare

ISSN： 1744-666X

Source： Expert Review of Clinical Immunology, Vol.9, Iss.6, 2013-06, pp. : 495-497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mantle cell lymphoma: established therapeutic options and future directions

By Lenz G.  

Annals of Hematology, Vol. 83, Iss. 2, 2004-02 ,pp. : 71-77

Springer Publishing Company

Access to resources Recommend Favorite

Molecular characterization of composite mantle cell and follicular lymphoma

By Zamò Alberto   Zanotti Roberta   Lestani Maurizio   Ott German   Katzenberger Tiemo   Scarpa Aldo   Pizzolo Giovanni   Menestrina Fabio   Chilosi Marco  

Virchows Archiv, Vol. 448, Iss. 5, 2006-05 ,pp. : 639-643

Springer Publishing Company

Access to resources Recommend Favorite

Primary mantle cell lymphoma of the conjunctiva: a case report

By Aspiotis Miltiadis   Gorezis Spiridon   Asproudis Ioannis   Tsanou Elena   Papadiotis Evangelos   Kamina Sevasti   Agnantis Niki   Bai Maria  

Virchows Archiv, Vol. 449, Iss. 4, 2006-10 ,pp. : 472-475

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of T-Cell lymphoma

By Hotta Tomomitsu  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 193-196

Maney Publishing

Access to resources Recommend Favorite

Lenalidomide, as a single agent, induces complete remission in a refractory mantle cell lymphoma

By Tempescul Adrian  

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 921-922

Springer Publishing Company

Access to resources Recommend Favorite